Dual or Multi-Agonists (GLP-1 + GIP or GLP-1 + Glucagon) This treatment stimulates multiple metabolic hormone receptors at once, such as GIP (glucose-dependent insulinotropic polypeptide) in addition to GLP-1
A therapeutic dose is the amount of a medication required to achieve the desired clinical effect without causing significant side effects
Sharp KG, Yee KM, Stiles TL, Aguilar RM, Steward O
Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnel WF, & Bromberg PA (1989) Ozone-induced inflammation in the lower airways of human subjects
Ploy Pitayanon, MD, licensed by the Medical Council of Thailand At a Glance Peptide BPC-157 Category Healing & Recovery Dosage 500 mcg to 1 mg per day subcutaneous (physician-prescribed)
Total Billed once Monthly virtual visits Access to AI assistant Premium customer support Select Your Current Weight (lbs.) Disclaimer These results are derived from two separate patient cohorts: (1) individuals with initial visits on or after March 1, 2024 and baseline weights exceeding 175 lbs, who recorded an average weight loss of 9.75 lbs within the first month of enrollment